Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride in schizophrenia: A 52-week, open-label trial (EMERGENT-5)

Schizophrenia Research 2026

View at publisher

Authors: Inder Kaul, Amy Claxton, Soumya A. Chaturvedi, Tejendra Patel, Hsiuanlin Wu, Sharon Sawchak, Colin Sauder

DOI: 10.1016/j.schres.2025.12.015

Cited by: 6

References: 20

Fields of Study & Subjects

Schizophrenia research and treatment Phosphodiesterase function and regulation Bipolar Disorder and Treatment

References 20